Cancer News

Dan L Duncan Comprehensive Cancer Center researchers awarded CPRIT grants to support the fight against cancerMay 25, 2016
Three researchers from the Dan L Duncan Comprehensive Cancer Center at Baylor have been awarded academic research program grants from the Cancer Prevention and Research Institute of Texas.
First large-scale proteogenomic study of breast cancer provides insight into potential therapeutic targetsMay 25, 2016
Researchers completed the first large-scale “proteogenomic” study of breast cancer, linking DNA mutations to protein signaling and helping pinpoint the genes that drive cancer.
Differences in metabolism between androgen-dependent and castration resistant prostate cancer may lead to new therapiesMay 19, 2016
Researchers have determined that castration resistant prostate cancer has particular metabolic characteristics that may open new possibilities for treatment. 
Researchers uncover marker important to effectiveness of natural killer T cellsMay 16, 2016
Researchers identified a molecular marker of NKT cells that could lead to effective cancer immunotherapy.
Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor growthMay 16, 2016
Baylor College of Medicine researchers report a new mechanism that helps cancer cells engage myeloid-derived suppressor for growth.
Baylor College of Medicine pediatric oncologist to lend expertise to national Moonshot initiativeMay 9, 2016
Dr. Will Parsons will be part of the efforts to accelerate pediatric cancer research through the National Cancer Moonshot Initiative.
Recipients of 2016 DeBakey Research Award represent Baylor College of Medicine’s scientific excellenceMay 3, 2016
Five Baylor faculty members have received the Michael E. DeBakey Excellence in Research Award .
Successful treatment for hepatitis C reduces risk of liver cancer later in veteransApr 22, 2016
A new study found that treatment and cure of chronic hepatitis C reduce the risk of the most common for of liver cancer.
New class of small molecule drug, SI-2, has potential for improving cancer treatmentApr 15, 2016
Baylor researchers find that SI-2 can inhibit tumor growth in mouse models and could be used to develop drugs against key drivers of many cancers.
Experts warn HPV related cancer on the rise in U.S.Apr 13, 2016
The last three decades have seen a rise in the cases of head and neck cancer and a shift in the cause of such cancers, according to experts at Baylor College of Medicine.